Peter Svennilson, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 109,343 shares at $17.91 ($2.0M) on 2020-02-28, disclosed to the SEC on 2020-02-28.
Open-market purchase of $2.0M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 3,751 | $68K | 3.4% |
| 2 | $17.91 | 33,896 | $607K | 31.0% |
| 3 | $17.91 | 33,896 | $607K | 31.0% |
| 4 | $17.91 | 37,800 | $677K | 34.6% |
| Total | $17.91 avg | 109,343 | $2.0M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |